This week’s View examines biomarkers early in pregnancy and their ability to predict hypertension risk and other disorders; clinical outcomes and pre-hospital delay among patients presenting with non–ST-segment elevation myocardial infarction (NSTEMI); and important ‘key points to remember’ from a state-of-the-art review on the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM).